retatrutide triple agonist weight loss trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational agonist. Learn more: https://go.lilly.com/msrz1v retatrutide mechanism retatrutide clinical trials

"Without concerted action, these medicines could contribute to widening the gap between the rich and poor, both between and within countries." A new generation of appetite-suppressing drugs called GLP-1 agonists -- which includes blockbuster brands Ozempic and Mounjaro -- has become massively popular in recent years

Skinny Shot Maintenance: Monthly After achieving target weight or metabolic goals, monthly Skinny Shots maintain liver function and fat metabolism support

Available research tells us that stimulants tend to produce highly variable responses in children with both ASD and ADHD symptoms

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy